| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 134 |
| 1 | ACETAMINOPHEN 500MG | 126 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 126 |
| 3 | PAIN RELIEVER | 126 |
| 4 | ATENOLOL | 124 |
| 5 | LANSOPRAZOLE | 120 |
| 6 | CETIRIZINE | 118 |
| 7 | CETIRIZINE HYDROCHLORIDE | 118 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 117 |
| 9 | ETANERCEPT | 117 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE VALERATE | 26 | 0.0414 |
| 1 | PYRIMETHAMINE | 9 | 0.0071 |
| 2 | TETRAHYDROZOLINE HYDROCHLORIDE | 2 | 0.0068 |
| 3 | CHLORPROMAZINE | 28 | 0.0045 |
| 4 | PRAZOSIN | 23 | 0.0037 |
| 5 | MANGANESE CHLORIDE | 1 | 0.0036 |
| 6 | PRAZOSIN HYDROCHLORIDE | 5 | 0.0036 |
| 7 | CETIRIZINE HYDROCHLORIDE TABLETS | 110 | 0.0035 |
| 8 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 46 | 0.0031 |
| 9 | METHYLPREDNISOLONE ACETATE | 22 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 166 |
| 1 | Corticosteroid [EPC] | 154 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 141 |
| 3 | Proton Pump Inhibitor [EPC] | 134 |
| 4 | beta-Adrenergic Blocker [EPC] | 129 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 123 |
| 6 | Benzodiazepine [EPC] | 121 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 103 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 90 |
| 9 | Vitamin C [EPC] | 83 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 9 | 0.0071 |
| 1 | Sulfonamide Antibacterial [EPC] | 9 | 0.0023 |
| 2 | alpha-Hydroxy Acid [EPC] | 3 | 0.0014 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 103 | 0.0012 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 141 | 0.0004 |
| 6 | beta-Adrenergic Blocker [EPC] | 129 | 0.0004 |
| 7 | Catecholamine [EPC] | 32 | 0.0004 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 25 | 0.0003 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |